Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Hanrong Feng

3PUBLICATIONS

104CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jul 24, 2025

A neomorphic protein interface catalyzes covalent inhibition of RAS<sup>G12D</sup> aspartic acid in tumors.

Caroline Weller, G Leslie Burnett, Lingyan Jiang

|Jul 08, 2024

Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer.

Julien Dilly, Megan T Hoffman, Laleh Abbassi

|Oct 11, 2023

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.

Brandon M Huffman, Hanrong Feng, Kalindi Parmar

Pageof 1

Frequent Collaborators

3 joint publications

Andrew J Aguirre

3 joint publications

Brian M Wolpin

2 joint publications

Jennifer Roth

2 joint publications

Julien Dilly

2 joint publications

Junning Wang

2 joint publications

Kevin S Kapner

2 joint publications

Seema Chugh

2 joint publications

Connor J Hennessey

2 joint publications

Srivatsan Raghavan

1 joint publications

Bose Kochupurakkal

Frequent Collaborators

3 joint publications

Andrew J Aguirre

3 joint publications

Brian M Wolpin

2 joint publications

Jennifer Roth

2 joint publications

Julien Dilly

Top Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on : Oct 04, 2022

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

See more related videos

Top Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on : Jul 17, 2019

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on : Oct 04, 2022

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on : Feb 02, 2024

See more related videos